- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07814443
The Effect of Acupressure on Restless Legs Syndrome and Pruritus in Patients Undergoing Hemodialysis (RLS/CKD-aP)
"Effect of Combined Traditional and Paraspinal Acupressure on Restless Legs Syndrome and Pruritus in Patients Undergoing Hemodialysis: A Randomized Controlled Trial
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Participants allocated to the intervention group will receive combined traditional and paraspinal acupressure in addition to routine hemodialysis care. The intervention will involve stimulation of selected acupressure points using a vibration acupressure device.
The paraspinal component will include selected thoracic and lumbar points (BL13, BL17, BL23, BL24, and BL25) and will be applied before the hemodialysis session. Traditional peripheral acupressure points, including SP6, SP10, ST36, LI11, LR3, and BL57, will be stimulated during the hemodialysis session.The intervention will be administered according to a standardized protocol regarding point localization, application technique, duration, and frequency to ensure consistency among participants. Participants will be observed during the intervention for any discomfort or adverse events.
Participants allocated to the control group will continue to receive routine hemodialysis care without the acupressure intervention during the study period.
Restless legs syndrome severity and pruritus severity will be evaluated using validated instruments at three predetermined assessment time points. The collected data will be used to examine changes in symptoms over time and differences between the two study groups.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Alaa Kadhim Abdul-Hameed, Assist lecturer
- Telefonnummer: +9647763497862
- E-post: alaa-kadhim@utq.edu.iq
Studieorter
-
-
Dhi Qar
-
Dhi-Qar, Dhi Qar, Irak, 64001
- Al-Hussien Hemodialysis center
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria
- Patients more than 18 years old on hemodialysis treatment for more than 2 sessions per week.
- The patients on hemodialysis for more than 3 months
- The patients who complain of restless leg syndrome and pruritus.
- RLS diagnosis meeting the diagnostic criteria defined by the International Restless Legs Syndrome Study Group (IRLSSG).
- At least moderate RLS symptoms (IRLS - total score ≥ 11)
- Patients who score more than five on the 5D Pruritus scale.
- Patient with a history of pruritus for more than 3 months.
Exclusion Criteria
- Patients with impaired skin integrity.
- Patients with skin lesions in areas involved in acupressure therapy.
- Patients with neurological deficits as perception of pain, may differ from other patients.
- Patients with a body mass index (BMI) of more than > 30 kg/m².
- Patients with malignancy.
- Patients with Jaundice.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: intervention group (Vibration assisted acupressure)
Participants in this group will receive vibration-assisted acupressure using an acupressure device applied to selected acupoints in addition to routine hemodialysis care.
The intervention will be administered according to the study protocol to evaluate its effects on restless legs syndrome and pruritus among patients undergoing
|
Vibration-assisted acupressure will be applied to selected traditional and paraspinal acupoints using a handheld vibration device.
The intervention is designed to reduce the severity of restless legs syndrome and pruritus in patients undergoing hemodialysis.
It will be administered according to a predefined intervention protocol in addition to routine hemodialysis care
|
|
Inget ingripande: CONTROL GROUP
Participants will receive routine hemodialysis care without the acupressure intervention
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Restless Legs Syndrome Severity Assessed by the International Restless Legs Syndrome Study Group Rating Scale (IRLS)
Tidsram: Baseline (before intervention), 1 month after initiation of the intervention, and 2 months after initiation of the intervention
|
The questionnaire consisted of 10 items, each of which had a scale ranging from 0 (no impact) to 4 (very severe impact).
RLS severity was defined as mild (0-10 points), moderate (11-20 points), severe (21-30 points), or very severe (31-40 points).
|
Baseline (before intervention), 1 month after initiation of the intervention, and 2 months after initiation of the intervention
|
|
Change in Pruritus Severity Assessed by the 5-D Itch Scale
Tidsram: Baseline (before intervention), 1 month after initiation of the intervention, and 2 months after initiation of the intervention
|
Pruritus severity will be assessed using the 5-D Itch Scale, which evaluates five dimensions of itching: duration, degree, direction, disability, and distribution.
The total score ranges from 5 to 25, with higher scores indicating greater severity and impact of pruritus
|
Baseline (before intervention), 1 month after initiation of the intervention, and 2 months after initiation of the intervention
|
Samarbetspartners och utredare
Sponsor
Utredare
- Studierektor: Hakima Shaker Hassan, Assist prof, College of Nursing/ University of Baghdad
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 133
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .